CSC
FOLD

Caldwell Sutter Capital’s Amicus Therapeutics FOLD Stock Holding History

Caldwell Sutter Capital’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$5.78K – 936
2026
Q1 		$5.78K Hold
400
– – ﹤0.01% 622
2025
Q4 		$5.7K Hold
400
– – ﹤0.01% 619
2025
Q3 		$3.15K Buy
400
+70
+21% +$498 ﹤0.01% 690
2025
Q2 		$1.89K Hold
330
– – ﹤0.01% 726
2025
Q1 		$2.69K Hold
330
– – ﹤0.01% 697
2024
Q4 		$3.11K Hold
330
– – ﹤0.01% 697
2024
Q3 		$3.52K Hold
330
– – ﹤0.01% 691
2024
Q2 		$3.27K Hold
330
– – ﹤0.01% 692
2024
Q1 		$3.89K Hold
330
– – ﹤0.01% 656
2023
Q4 		$4.68K Hold
330
– – ﹤0.01% 638
2023
Q3 		$4.01K Hold
330
– – ﹤0.01% 634
2023
Q2 		$4.14K Buy
+330
New +$3.92K ﹤0.01% 636

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Caldwell Sutter Capital's FOLD Position: Q2 2026 in Review

Caldwell Sutter Capital sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 400 shares — an estimated $5.78K sold.

Caldwell Sutter Capital first reported a position in FOLD in Q2 2023 and held it in 12 quarters. The position peaked at $5.78K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Caldwell Sutter Capital reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Caldwell Sutter Capital sold 400 Amicus Therapeutics shares in Q2 2026, an estimated $5.78K.
  • Caldwell Sutter Capital first reported a position in Amicus Therapeutics in Q2 2023 and held it in 12 quarters.
  • Caldwell Sutter Capital's Amicus Therapeutics position peaked at $5.78K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.